AtaiBeckley (ATAI) Current Assets (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Current Assets of $250.1 million in Q1 2026, down 9.29% quarter-over-quarter from $275.7 million in Q4 2025.

AtaiBeckley (ATAI) Current Assets (2020 - 2026) Analysis & Trends

AtaiBeckley's Current Assets history runs 3 years deep, the most recent figure standing at $250.1 million for Q1 2026.

  • In Q1 2026, Current Assets changed N/A year-over-year to $250.1 million; the TTM figure through Mar 2026 stood at $250.1 million (changed N/A YoY), while the FY2025 annual figure was $275.7 million, up 244.07% from the prior year.
  • Current Assets was $250.1 million for Q1 2026 at AtaiBeckley, down from $275.7 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $457.6 million in Q2 2021 to a low of $80.1 million in Q4 2024.
  • The 5-year median for Current Assets is $229.3 million (2023), against an average of $235.7 million.
  • Biggest YoY gain for Current Assets was 244.07% in 2025; the steepest drop was 244.07% in 2025.
  • A 3-year view of Current Assets shows it stood at $80.1 million in 2024, then soared by 244.07% to $275.7 million in 2025, then declined by 9.29% to $250.1 million in 2026.
  • The last three Current Assets figures came in at $250.1 million (Q1 2026), $275.7 million (Q4 2025), and $80.1 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.31 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 521.86 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 10.37 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.25 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 3.59 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.63 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 11.73 Bn
9 Abivax 91.96 Bn 91.96 Bn - 600.85 Mn
10 AtaiBeckley 1.45 Bn 1.45 Bn - 250.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 250.07 Mn
Dec 31, 2025 275.68 Mn
Sep 30, 2025 130.67 Mn
Jun 30, 2025 102.68 Mn
Mar 31, 2025 115.98 Mn
Dec 31, 2024 80.13 Mn
Dec 31, 2024 80.13 Mn
Sep 30, 2024 114.07 Mn
Jun 30, 2024 117.91 Mn
Mar 31, 2024 117.50 Mn
Dec 31, 2023 185.59 Mn
Sep 30, 2023 215.83 Mn
Jun 30, 2023 242.77 Mn
Mar 31, 2023 267.93 Mn
Dec 31, 2022 287.15 Mn
Sep 30, 2022 317.48 Mn
Jun 30, 2022 323.61 Mn
Mar 31, 2022 348.79 Mn
Dec 31, 2021 375.08 Mn
Sep 30, 2021 441.86 Mn